Table 2.
Distribution of progesterone routes according to the number of clinicians and dosage.
Progesterone routes | Clinicians%(n) | Dosage (mg/day) |
---|---|---|
Vaginal | 80% (119/148) | 600 mg/d (103/119) 200/400 mg/d (16/119) |
Vaginal + OS | 2% (3/148) | 600/400 mg/d +20–30 mg/d (3/148) |
Vaginal + IM | 2% (3/148) | 600/400 mg/d + 50 mg/d (3/148) |
IM | 6% (9/148) | 50–100 mg/d (9/148) |
Subcutaneous | 5% (7/148) | 25 mg/d (7/148) |
OS | 5% (7/148) | 20–30 mg/d (7/148) |
OS: oral, IM: intramuscular. Vaginal route agent: micronized progesterone tablets 200 mg.